human dmd myoblasts Search Results


2174 dmd mouse primary satellite cells  (ATCC)
94
ATCC 2174 dmd mouse primary satellite cells
2174 Dmd Mouse Primary Satellite Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/2174 dmd mouse primary satellite cells/product/ATCC
Average 94 stars, based on 1 article reviews
2174 dmd mouse primary satellite cells - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
human dmd myoblasts  (PromoCell)
98
PromoCell human dmd myoblasts
(A) Schematic representation of the timeline for generating 3D mini muscle starting from treated or <t>untreated</t> <t>myoblasts.</t> (B) TIDE quantification of the indels generated by the gRNA Let-7c-1 in 3D hDMD mini-muscle. Bars represent mean ± SEM of n = 3 per condition. Dots represent each experiment. (C) Indel profiles generated by the gRNA-hLet-7c-1 in 3D hDMD mini-muscle. In the inset are indicated the % at which each nucleotide is inserted in the +1 indels. Bars are mean ± SEM of n = 3 per condition. (D) Quantitative PCR analysis of utrophin A mRNA expression level, normalized with gapdh, after editing with the indicated gRNAs in 3D hDMD mini-muscle. Bars are mean ± SEM of n = 3 per condition. Dots represent each experiment. *p < 0.05. (E) Relative utrophin protein expression in 3D <t>DMD</t> muscles after editing with the indicated gRNA was determined by western blot and standardized for GAPDH loading. Bar graph: WB quantification. Bars represent mean ± SEM of n = 2 per condition. Dots represent each experiment. (F) Immunofluorescence staining for utrophin and myosin heavy chain (MyHC) on transverse sections of 3D DMD muscles show a higher utrophin signal after treatment with gRNA-hLet-7c compared to control. n = 4 per group. Scale bar: 100 µm. (G) Quantification of the immunostaining shown in (F) . Bars represent mean ± SEM of n = 3 per condition. Dots represent each experiment.
Human Dmd Myoblasts, supplied by PromoCell, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human dmd myoblasts/product/PromoCell
Average 98 stars, based on 1 article reviews
human dmd myoblasts - by Bioz Stars, 2026-03
98/100 stars
  Buy from Supplier
human muscle tissues non-dmd subjects  (ProteoGenex Inc)
90
ProteoGenex Inc human muscle tissues non-dmd subjects
(A) Schematic representation of the timeline for generating 3D mini muscle starting from treated or <t>untreated</t> <t>myoblasts.</t> (B) TIDE quantification of the indels generated by the gRNA Let-7c-1 in 3D hDMD mini-muscle. Bars represent mean ± SEM of n = 3 per condition. Dots represent each experiment. (C) Indel profiles generated by the gRNA-hLet-7c-1 in 3D hDMD mini-muscle. In the inset are indicated the % at which each nucleotide is inserted in the +1 indels. Bars are mean ± SEM of n = 3 per condition. (D) Quantitative PCR analysis of utrophin A mRNA expression level, normalized with gapdh, after editing with the indicated gRNAs in 3D hDMD mini-muscle. Bars are mean ± SEM of n = 3 per condition. Dots represent each experiment. *p < 0.05. (E) Relative utrophin protein expression in 3D <t>DMD</t> muscles after editing with the indicated gRNA was determined by western blot and standardized for GAPDH loading. Bar graph: WB quantification. Bars represent mean ± SEM of n = 2 per condition. Dots represent each experiment. (F) Immunofluorescence staining for utrophin and myosin heavy chain (MyHC) on transverse sections of 3D DMD muscles show a higher utrophin signal after treatment with gRNA-hLet-7c compared to control. n = 4 per group. Scale bar: 100 µm. (G) Quantification of the immunostaining shown in (F) . Bars represent mean ± SEM of n = 3 per condition. Dots represent each experiment.
Human Muscle Tissues Non Dmd Subjects, supplied by ProteoGenex Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human muscle tissues non-dmd subjects/product/ProteoGenex Inc
Average 90 stars, based on 1 article reviews
human muscle tissues non-dmd subjects - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


(A) Schematic representation of the timeline for generating 3D mini muscle starting from treated or untreated myoblasts. (B) TIDE quantification of the indels generated by the gRNA Let-7c-1 in 3D hDMD mini-muscle. Bars represent mean ± SEM of n = 3 per condition. Dots represent each experiment. (C) Indel profiles generated by the gRNA-hLet-7c-1 in 3D hDMD mini-muscle. In the inset are indicated the % at which each nucleotide is inserted in the +1 indels. Bars are mean ± SEM of n = 3 per condition. (D) Quantitative PCR analysis of utrophin A mRNA expression level, normalized with gapdh, after editing with the indicated gRNAs in 3D hDMD mini-muscle. Bars are mean ± SEM of n = 3 per condition. Dots represent each experiment. *p < 0.05. (E) Relative utrophin protein expression in 3D DMD muscles after editing with the indicated gRNA was determined by western blot and standardized for GAPDH loading. Bar graph: WB quantification. Bars represent mean ± SEM of n = 2 per condition. Dots represent each experiment. (F) Immunofluorescence staining for utrophin and myosin heavy chain (MyHC) on transverse sections of 3D DMD muscles show a higher utrophin signal after treatment with gRNA-hLet-7c compared to control. n = 4 per group. Scale bar: 100 µm. (G) Quantification of the immunostaining shown in (F) . Bars represent mean ± SEM of n = 3 per condition. Dots represent each experiment.

Journal: bioRxiv

Article Title: CRISPR-Cas9 mediated endogenous utrophin upregulation improves Duchenne Muscular Dystrophy

doi: 10.1101/2023.04.18.536394

Figure Lengend Snippet: (A) Schematic representation of the timeline for generating 3D mini muscle starting from treated or untreated myoblasts. (B) TIDE quantification of the indels generated by the gRNA Let-7c-1 in 3D hDMD mini-muscle. Bars represent mean ± SEM of n = 3 per condition. Dots represent each experiment. (C) Indel profiles generated by the gRNA-hLet-7c-1 in 3D hDMD mini-muscle. In the inset are indicated the % at which each nucleotide is inserted in the +1 indels. Bars are mean ± SEM of n = 3 per condition. (D) Quantitative PCR analysis of utrophin A mRNA expression level, normalized with gapdh, after editing with the indicated gRNAs in 3D hDMD mini-muscle. Bars are mean ± SEM of n = 3 per condition. Dots represent each experiment. *p < 0.05. (E) Relative utrophin protein expression in 3D DMD muscles after editing with the indicated gRNA was determined by western blot and standardized for GAPDH loading. Bar graph: WB quantification. Bars represent mean ± SEM of n = 2 per condition. Dots represent each experiment. (F) Immunofluorescence staining for utrophin and myosin heavy chain (MyHC) on transverse sections of 3D DMD muscles show a higher utrophin signal after treatment with gRNA-hLet-7c compared to control. n = 4 per group. Scale bar: 100 µm. (G) Quantification of the immunostaining shown in (F) . Bars represent mean ± SEM of n = 3 per condition. Dots represent each experiment.

Article Snippet: Human DMD myoblasts were maintained in Smooth Muscle Cell Growth Medium (C-23060, PromoCell) supplemented with 20% fetal bovine serum gold (PAA) and 1% penicillin– streptomycin (Invitrogen).

Techniques: Generated, Real-time Polymerase Chain Reaction, Expressing, Muscles, Western Blot, Immunofluorescence, Staining, Control, Immunostaining